Tadamune Otsubo

Tadamune Otsubo


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
TOTadamune Otsubo
Tadamune Otsubo
AMAkira Minami
Akira Minami
HFHaruna Fujii
Haruna Fujii
RTRisa Taguchi
Risa Taguchi
TTTadanobu Takahashi
Tadanobu Takahashi
KIKiyoshi Ikeda
Kiyoshi Ikeda

1 September 2014 in Virology
Verified
Journal Article
Closed access
MTMaiko Takano
Maiko Takano
TTTadanobu Takahashi
Tadanobu Takahashi
TATakashi Agarikuchi
Takashi Agarikuchi
YKYuuki Kurebayashi
Yuuki Kurebayashi
AMAkira Minami
Akira Minami
TSTakashi Suzuki
Takashi Suzuki

26 October 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Akira MinamiAkira Minami
Akira Minami
MSMasakazu Saito
Masakazu Saito
SMShou Mamada
Shou Mamada
DIDaisuke Ieno
Daisuke Ieno
THTomoya Hikita
Tomoya Hikita
TSTakashi Suzuki
Takashi Suzuki
Sialic acid bound to glycans in glycolipids and glycoproteins is essential for synaptic plasticity and memory. Sialidase (EC 3.2.1.18), which has 4 isozymes including Neu1, Neu2, Neu3 and Neu4, regulates the sialylation level of glycans by removing sialic acid from sialylglycoconjugate. In the present study, we investigated the distribution of sialidase activity in rat hippocampus and the role of sialidase in hippocampal memory processing. We previously developed a highly sensitive histochemical imaging probe for sialidase activity, BTP3-Neu5Ac. BTP3-Neu5Ac was cleaved efficiently by rat Neu2 and Neu4 at pH 7.3 and by Neu1 and Neu3 at pH 4.6. When a rat hippocampal acute slice was stained with BTP3-Neu5Ac at pH 7.3, mossy fiber terminal fields showed relatively intense sialidase activity. Thus, the role of sialidase in the synaptic plasticity was investigated at mossy fiber terminal fields. The long-term potentiation (LTP) at mossy fiber-CA3 pyramidal cell synapses was impaired by 2,3-dehydro-2-deoxy-N-acetylneuraminic acid (DANA), a sialidase inhibitor. DANA also failed to decrease paired-pulse facilitation after LTP induction. We also investigated the role of sialidase in hippocampus-dependent spatial memory by using the Morris water maze. The escape latency time to reach the platform was prolonged by DANA injection into the hippocampal CA3 region or by knockdown of Neu4 without affecting motility. The results show that the regulation of sialyl signaling by Neu4 is involved in hippocampal memory processing.

27 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YKYuuki Kurebayashi
Yuuki Kurebayashi
TTTadanobu Takahashi
Tadanobu Takahashi
CTChihiro Tamoto
Chihiro Tamoto
KSKeiji Sahara
Keiji Sahara
TOTadamune Otsubo
Tadamune Otsubo
TSTakashi Suzuki
Takashi Suzuki
Influenza A and B viruses possess a neuraminidase protein that shows sialidase activity. Influenza virus-specific neuraminidase inhibitors (NAIs) are commonly used for clinical treatment of influenza. However, some influenza A and B viruses that are resistant to NAIs have emerged in nature. NAI-resistant viruses have been monitored in public hygiene surveys and the mechanism underlying the resistance has been studied. Here, we describe a new assay for selective detection and isolation of an NAI-resistant virus in a speedy and easy manner by live fluorescence imaging of viral sialidase activity, which we previously developed, in order to achieve high-efficiency capture of an NAI-resistant virus. An NAI-resistant virus maintains sialidase activity even at a concentration of NAI that leads to complete deactivation of the virus. Infected cells and focuses (infected cell populations) of an oseltamivir-resistant virus were selectively visualized by live fluorescence sialidase imaging in the presence of oseltamivir, resulting in high-efficiency isolation of the resistant viruses. The use of a combination of other NAIs (zanamivir, peramivir, and laninamivir) in the imaging showed that the oseltamivir-resistant virus isolated in 2008 was sensitive to zanamivir and laninamivir but resistant to peramivir. Fluorescence imaging in the presence of zanamivir also succeeded in selective live-cell visualization of cells that expressed zanamivir-resistant NA. Fluorescence imaging of NAI-resistant sialidase activity will be a powerful method for study of the NAI resistance mechanism, for public monitoring of NAI-resistant viruses, and for development of a new NAI that shows an effect on various NAI-resistant mutations.

Verified
Journal Article
Open access
PDF file
Akira MinamiAkira Minami
Akira Minami
YKYuuki Kurebayashi
Yuuki Kurebayashi
TTTadanobu Takahashi
Tadanobu Takahashi
TOTadamune Otsubo
Tadamune Otsubo
KIKiyoshi Ikeda
Kiyoshi Ikeda
TSTakashi Suzuki
Takashi Suzuki
Sialidase cleaves sialic acid residues from glycans such as glycoproteins and glycolipids. In the brain, desorption of the sialic acid by sialidase is essential for synaptic plasticity, learning and memory and synaptic transmission. BTP3-Neu5Ac has been developed for sensitive imaging of sialidase enzyme activity in mammalian tissues. Sialidase activity in the rat hippocampus detected with BTP3-Neu5Ac increases rapidly by neuronal depolarization. It is presumed that an increased sialidase activity in conjunction with neural excitation is involved in the formation of the neural circuit for memory. Since sialidase inhibits the exocytosis of the excitatory neurotransmitter glutamate, the increased sialidase activity by neural excitation might play a role in the negative feedback mechanism against the glutamate release. Mammalian tissues other than the brain have also been stained with BTP3-Neu5Ac. On the basis of information on the sialidase activity imaging in the pancreas, it was found that sialidase inhibitor can be used as an anti-diabetic drug that can avoid hypoglycemia, a serious side effect of insulin secretagogues. In this review, we discuss the role of sialidase in the brain as well as in the pancreas and skin, as revealed by using a sialidase activity imaging probe. We also present the detection of influenza virus with BTP3-Neu5Ac and modification of BTP3-Neu5Ac.

1 August 2024 in Glycobiology
Verified
Journal Article
Closed access
PDF file
TTTadanobu Takahashi
Tadanobu Takahashi
YKYuuki Kurebayashi
Yuuki Kurebayashi
TOTadamune Otsubo
Tadamune Otsubo
KIKiyoshi Ikeda
Kiyoshi Ikeda
KKKobun Konagaya
Kobun Konagaya
Hideyuki TakeuchiHideyuki Takeuchi
Hideyuki Takeuchi
The prevalent human pathogen, mumps virus (MuV; orthorubulavirus parotitidis) causes various complications and serious sequelae, such as meningitis, encephalitis, deafness, and impaired fertility. Direct-acting antivirals (DAAs) targeting MuV which can prevent mumps and mumps-associated complications and sequelae are yet to be developed. Paramyxoviridae family members, such as MuV, possess viral surface hemagglutinin-neuraminidase (HN) protein with sialidase activity which facilitates efficient viral replication. Therefore, to develop DAAs targeting MuV we synthesized MuV sialidase inhibitors. It is proposed that the viral HN has a single functional site for N-acetylneuraminic acid (Neu5Ac) binding and sialidase activity. Further, the known MuV sialidase inhibitor is an analog of Neu5Ac—2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA)—which lacks potency. DANA derivatives with higher MuV sialidase inhibitory potency are lacking. The MuV-HN–Neu5Ac binding site has a hydrophobic cavity adjacent to the C4 position of Neu5Ac. Exploiting this, here, we synthesized DANA derivatives with increasing hydrophobicity at its C4 position and created 3 novel sialidase inhibitors (Compounds 1, 2 and 3) with higher specificity for MuV-HN than DANA; they inhibited MuV replication step to greater extent than DANA. Furthermore, they also inhibited hemagglutination and the MuV infection step. The insight—that these 3 novel DANA derivatives possess linear hydrocarbon groups at the C4-hydroxyl group of DANA—could help develop highly potent sialidase inhibitors with high specificity for MuV sialidase, which may function as direct-acting MuV-specific antivirals.